This inventor holds 10 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 18 EPO patents. Top assignees: Commonwealth Scientific and Industrial Research Organisation, Clinical Genomics Pty. Ltd., The Commonwealth of Australia. Active years: 2006-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New South Wales, AU (2006 - 2013)
- Chatswood, AU (2006 - 2022)
Company Filing History:
9 out of 1,355 
3 out of 10 
1 out of 160 
Years Active: 2006-2022
Title: The Innovative Contributions of Peter Laurence Molloy in Colorectal Cancer Research
Introduction
Peter Laurence Molloy, an accomplished inventor located in New South Wales, Australia, has been instrumental in advancing the field of medical diagnostics through his innovative work in colorectal cancer research. With a remarkable portfolio comprising 10 patents, Peter has made significant contributions that aim to improve the diagnosis and understanding of neoplasms.
Latest Patents
Among Peter's most significant inventions are two key patents focused on colorectal cancer screening. The first, a "Diagnostic Gene Marker Panel for Colorectal Cancer," relates to a method for screening individuals for the onset, predisposition to, and progression of neoplasms. This innovative method involves analyzing changes in methylation levels of a specific panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP, and CAHM. The applications of this invention have vast implications for diagnosing and monitoring colorectal neoplasms, such as colorectal adenocarcinoma.
The second notable patent, "Genome Methylation Analysis," presents methods for identifying specific sites and regions within a gene or genome that are suitable for methylation analysis. The techniques disclosed allow efficient identification on a genome-wide scale, paving the way for targeted analysis and further advancements in gene research.
Career Highlights
Peter has worked at prestigious organizations, including the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and Clinical Genomics Pty. Ltd. His work at these institutions underscores his commitment to research and innovation, especially in the realm of cancer diagnostics.
Collaborations
Throughout his career, Peter has collaborated with notable individuals such as Lawrence Charles Lapointe and Susanne Kartin Pedersen. These partnerships highlight the collaborative spirit within the scientific community and the importance of teamwork in driving innovation.
Conclusion
Peter Laurence Molloy's contributions to medical science, particularly in the diagnostics of colorectal cancer, exemplify the role of inventors in enhancing our understanding of complex diseases. His patents not only demonstrate his innovative capabilities but also hold the potential to significantly impact patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile